.png)
Current Clinical Trials
Hypogonadism
The goal of this clinical trial is to evaluate three doses of the drug leflutrozole on improvement of semen quality in men with hypogonadotropic hypogonadism, a condition that affects hormone levels and fertility. It will also study the safety of leflutrozole.
Participants must be adult men aged 18-49 years who are not currently taking testosterone replacement therapy.
​
​
​
​​
​
Female Sexual Dysfunction
A single-center, open-label, home-use early feasibility assessment of a novel topical gel [WSD4000] for the treatment of the symptoms of sexual dysfunction in a population of pre- and post- menopausal adult women.
​Observational Study
To assess differences in the fecal microbiota and metabolome associated with insufficient and sufficient sleep, and to evaluate the response and recovery of the microbiota to changes in participant sleep profiles.
Participants must be working men and women aged 20- 40 years in good physical health.
​
​
​​​​​​​​​​​​Stress Urinary Incontinence
Females ages 18-55 diagnosed with stress urinary incontinence with no history of prior treatment may be eligible.
​
​
​​
​​
Bladder Cancer
A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Subjects with Intermediate Risk (IR) Non-Muscle Invasive Bladder Cancer (NMIBC).
The subjects must have undergone adequate Transurethral Resection of Bladder Tumor (TURBT) during screening with or without peri-operative intravesical chemotherapy within 60 days prior randomization, and must have one of the following, confirmed by a diagnostic pathology report:
-
Recurrence within 1 year, low-grade Ta
-
Solitary low-grade Ta >3 cm
-
Low-grade Ta, multifocal
-
High-grade Ta, ≤3 cm
-
Low-grade T1
​​
​
​
​​
​Urinary Tract Infection
​Selected participation criteria:​
-
Women between the ages 18-75
-
Have had at least one UTI in past 12 months
-
Have a current UTI
​​
​
​
​
​​​To see if you qualify for one of the above trials, please send us an email.